URL has been copied successfully!
On this week’s episode of “The Readout LOUD,” we chat with longtime biotech executive Jeremy Levin about his new book, “Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust.” That sounds alarmist, and it is in some respects, but as Levin explains, the book is also a roadmap to a brighter future for the biotech industry.
But first, we recap the week’s biotech news, including an Eli Lilly gene-editing treatment for high cholesterol, a new round of funding for a longevity startup, and a preview of the upcoming ASCO cancer research meeting.
Please follow us:
